DOTA-CXCR4-L
Ref. TM-T80216
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Thursday 12 Dec 2024
Product Information
Name:
DOTA-CXCR4-L
Description:
DOTA-CXCR4-L, a peptide targeting the CXCR4 receptor, is utilized in cancer research, notably in the contexts of glioblastoma and triple-negative breast cancer
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
1223.34
Formula:
C58H78N16O14
Purity:
98%
Color/Form:
Liquid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T80216 DOTA-CXCR4-L
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
